Palliative care has often challenged the status quo. With the wider health agenda focused on technology, cure and waiting lists, palliative care has strongly supported and valued quality care of the dying, the patients agenda and multidisciplinary working. Yet when faced with the new frontier of palliative care in non-malignant disease, the palliative care movement seems cautious, perhaps even daunted.
No takes yet. Share an insight, caveat, or question.
Michael P. Connolly (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: